Clinical Trial Update: An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer

View source ↗

Summary

Open-label, prospective, multicentre, non-interventional study of apatinib for chemotherapy-refractory advanced/metastatic gastric cancer; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Metastatic Gastric Cancer | Status: UNKNOWN